BioregulatorEmerging Evidence✦ Khavinson Bioregulator

Khavinson Bioregulators Overview

Also known as: Peptide bioregulators, Cytomaxes, Cytogens

Comprehensive system of organ-specific peptide bioregulators developed by Professor Vladimir Khavinson for targeted tissue regeneration and anti-aging.

Benefits

7

Conditions

6

Evidence

40+ years Russian research, 50+ approved preparations, limited Western validation+ studies

Source

Synthetic short peptides (2-4 amino acids) targeting specific organs

Overview

Comprehensive system of organ-specific peptide bioregulators developed by Professor Vladimir Khavinson for targeted tissue regeneration and anti-aging.

Mechanism of Action

Short peptides (2-4 amino acids) that penetrate cell nucleus, bind specific DNA regions to regulate gene expression in target tissues, organ-specific bioregulation via epigenetic mechanisms, restore physiologic function and support healthy aging.

Key Benefits

  • Organ-specific regeneration
  • Epigenetic regulation of aging
  • Restore physiologic function
  • Prevent age-related decline
  • Minimal side effects
  • Cumulative benefits with repeated cycles
  • Comprehensive anti-aging system

Clinical Applications

Age-related organ declineChronic degenerative diseasesPreventative anti-agingRecovery from illnessLongevity optimizationTissue-specific dysfunction

Dosing Guidelines

Oral (bioregulators have oral bioavailability)

Typical Dose10-20 mg per bioregulator
FrequencyOnce daily
Duration20-30 day cycles, 2-4 times per year

Sublingual

Typical Dose10 mg
FrequencyOnce daily
Duration20-30 day cycles

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Emerging
Studies

40+ years Russian research, 50+ approved preparations, limited Western validation

Summary

Khavinson's life work spanning 40+ years with extensive Russian clinical use. Over 50 bioregulator preparations approved in Russia. Mechanisms supported by epigenetic research. Limited large-scale Western RCTs but substantial Russian medical literature and real-world experience.

Safety Information

Potential Side Effects

  • Minimal across the system
  • Excellent safety profile
  • Very well-tolerated

Contraindications

  • Pregnancy
  • Breastfeeding
  • Acute illness (relative for some)

Interactions

  • Generally minimal
  • May complement other therapies

Quick Facts

CategoryBioregulator
SourceSynthetic short peptides (2-4 amino acids) targeting specific organs
Legal StatusApproved as pharmaceuticals/supplements in Russia; dietary supplements elsewhere
Gabriel Brain Score
91/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.